Josh Abramson

Josh Abramson

Auto-generated profile, based on publicly available information

Josh Abramson

Google DeepMind, London, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
JAJosh Abramson
Josh Abramson
JAJonas Adler
Jonas Adler
JDJack Dunger
Jack Dunger
RERichard Evans
Richard Evans
TGTim Green
Tim Green
JJJohn M. Jumper
John M. Jumper
The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2–6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein–ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein–nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody–antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework.

27 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
JAJosh Abramson
Josh Abramson
JAJonas Adler
Jonas Adler
JDJack Dunger
Jack Dunger
RERichard Evans
Richard Evans
TGTim Green
Tim Green
JJJohn M. Jumper
John M. Jumper

30 September 2026 in Nature
Verified
Journal Article
Open access
PDF file
DSDavid Stutz
David Stutz
ACAlexander I. Cowen-Rivers
Alexander I. Cowen-Rivers
GOGuillermo Ortiz-Jimenez
Guillermo Ortiz-Jimenez
JRJeremy Ratcliff
Jeremy Ratcliff
VZVinicius Zambaldi
Vinicius Zambaldi
PKPushmeet Kohli
Pushmeet Kohli
Generative artificial intelligence (AI) models are revolutionizing biology, with tools such as AlphaFold 3 and protein design models accelerating breakthroughs in protein structure prediction and the creation of new functional proteins 1 . Tracking and establishing the provenance of AI-generated protein sequences and structures is becoming increasingly important to tackle a range of emerging challenges, including biosecurity and concerns about information veracity 2–4 . Here we introduce SynthIDBio, a family of methods for watermarking protein sequences and structures to establish the provenance of those generated with AI. SynthIDBio-sequence actively embeds a watermark into protein sequences while preserving function. We demonstrate this by creating watermarked, functional designed protein binders with binding affinity comparable with non-watermarked counterparts and near-perfect watermark detection accuracy. Furthermore, SynthIDBio-structure, a fine-tuned AlphaFold3 model, embeds an imperceptible watermark into biomolecular structures. Our work is a proof-of-concept that function-preserving biological watermarking is feasible, introducing a potential tool for provenance in the rapidly expanding era of AI-driven biological engineering.

5 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZWZachary Wu
Zachary Wu
JAJosh Abramson
Josh Abramson
TFThomas Frerix
Thomas Frerix
ACAlexander E. Chu
Alexander E. Chu
RZRuijie K. Zhang
Ruijie K. Zhang
JWJue Wang
Jue Wang
Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences 1 . Traditional protein engineering 2,3 is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles 4 , but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 5 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.

2 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZLZi-Qi Li
Zi-Qi Li
RZRuijie K. Zhang
Ruijie K. Zhang
PXPei-Pei Xie
Pei-Pei Xie
JKJacob Kelly
Jacob Kelly
YZYu Zhang
Yu Zhang
FAFrances H. Arnold
Frances H. Arnold
Directed evolution and machine-learning-assisted evolution have transformed biocatalysis by enabling rapid optimisation of catalytic performance within compatible protein scaffolds. In parallel, advances in deep-learning-driven de novo protein design have expanded accessible protein architectural space, enabling the generation of functional catalysts for increasingly challenging transformations. We herein report a synergistic design-evolution strategy to encode new-to-nature regio- and enantioselective C–H amination reactions using engineered de novo haemproteins to synthesise chiral piperidines, a privileged pharmacophore in drug discovery. By integrating motif scaffolding, computational re-design, and directed evolution, we demonstrate de novo enzyme design can enable challenging, high-energy-barrier enzyme chemistry with programmable regio- and enantioselectivity, high catalytic efficiency, excellent enzyme stability, and scaffold diversity.